FDA Inspection 1260555 - A Plus Phlebotomy Services - February 10, 2025

FDA Inspection 1260555 for A Plus Phlebotomy Services on February 10, 2025. Classification: Voluntary Action Indicated (VAI).

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA Inspection 1260555 for A Plus Phlebotomy Services on February 10, 2025. Classification: Voluntary Action Indicated (VAI).

Violation Codes

21 CFR 606.100(b)

21 CFR 606.121(c)(12)

21 CFR 606.160(a)(1)

21 CFR 606.60(a)

21 CFR 610.40(a)

21 CFR 610.40(a)(2)

21 CFR 630.10(e)

21 CFR 630.15(b)(1)

21 CFR 630.5(d)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

A Plus Phlebotomy Services

Inspection Date

February 10, 2025

Product Type

Biologics

Office

Center for Biologics Evaluation and Research

ID: f8a1ff1b-92b8-4417-a0b2-03e2343b8aca

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox